Home Cannabis Tilray: Analysts' Recommendations and Target Price

Tilray: Analysts’ Recommendations and Target Price

Tilray

Tilray (TLRY) has been one of the most volatile stocks in the cannabis sector compared to Canopy Growth (WEED), Aurora Cannabis (ACB), and Cronos Group (CRON). The company has a low float compared to its peers (HMMJ), which makes it riskier for investors.

Tilray Analysts' NTM Recommendations and Targets 2019-02-12

Target price

As of February 12, analysts’ consensus target price for Tilray was $131, which was nearly 3% higher from $127 in January. The company’s median target price was lower than the mean target price at $120 in February, which remained largely unchanged from a month ago. On February 12, the company closed at $75.9. The current mean target price would translate into an upside of ~72.8% if the current price converged with the target.

Analysts’ recommendations

In the above chart, six analysts covered Tilray stock and had an overall “buy” recommendation. None of the analysts had a “strong buy” on the stock. Three analysts recommended a “buy,” three analysts recommended a “hold,” and none of the analysts recommended a “sell.”

Next, we’ll discuss analysts’ recommendations for Aphria.

Must Read